| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | -333 | 98 | ||
| Asset impairment | 0 | 0 | ||
| General and administrative | 957 | 787 | ||
| Total operating expenses | 624 | 885 | ||
| Loss from operations | -624 | -885 | ||
| Other income | 0 | 0 | ||
| Interest income, net | 156 | 123 | ||
| Total other income | 156 | 123 | ||
| Net loss | -468 | -762 | ||
| Earnings per share, basic | -0.07 | -0.19 | ||
| Earnings per share, diluted | -0.07 | -0.19 | ||
| Weighted average number of shares outstanding, basic | 6,241,658 | 4,021,276 | ||
| Weighted average number of shares outstanding, diluted | 6,241,658 | 4,021,276 | ||
MUSTANG BIO, INC. (MBIO)
MUSTANG BIO, INC. (MBIO)